Is bacterial ash the flash that ignites NASH?

Gut

Volumn 48, Issue 2, 2001, Pages 148-149

  Farrell, G C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FATTY LIVER; HUMAN; INSULIN RESISTANCE; NOTE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

BACTERIAL TOXINS; CYTOKINES; FATTY LIVER; HEPATITIS; HUMANS; INTESTINES;

EID: 0035121972     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.2.148     Document Type: Note

References (23)

1. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
2. Non-alcoholic steatohepatitis: Another disease of affluence
3. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
4. Steatohepatitis: A tale of two "hits"?
5. Activation of hepatic stellate cells by TGF alpha and collagen type 1 is mediated by oxidative stress through c-myb expression
6. Cytokines in alcoholic liver disease
7. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
8. Increased hepatic CYP2E1 expression in rat model of hepatic steatosis with inflammation
9. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
10. Steatohepatitis, spontaneous peroxisomal proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisomal proliferator-activated receptor α natural ligand metabolism
11. CYP2E1 is not involved in early alcohol-induced liver injury
12. Oxidant stress in rat liver after lipopolysaccharide administration: Effect of inducible nitric-oxide synthase inhibition
13. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
14. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: Potential mechanism for sensitization to liver damage
15. Doxycycline in the prevention of hepatic dysfunction: An evaluation of its use following jejunoileal bypass in humans
16. Hepatobiliary complications of total parenteral nutrition
17. Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth
18. Effect of improved absorption on development of jejunileal bypass-induced liver dysfunction in rats
19. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatiits
20. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline
21. Tumor necrosis factor-α. A key component of the obesity-diabetes link
22. Liver pathology and the metabolic syndrome X in severe obesity
23. Non-alcoholic fatty liver: Another feature of the metabolic syndrome?